VibeOne analyzed 100+ CKD programs and found a clear pattern: small molecules dominate and repurposed drugs win. The next kidney breakthrough may already be in a cardiovascular trial. The post Scientific insights: CKD appeared first on Vibe Bio .
Need help?
Contact usVibeOne analyzed 100+ CKD programs and found a clear pattern: small molecules dominate and repurposed drugs win. The next kidney breakthrough may already be in a cardiovascular trial. The post Scientific insights: CKD appeared first on Vibe Bio .